A patient with a history of COPD presents with increased fatigue, worsening shortness of breath, cyanosis, and a productive cough with yellow-green sputum. Arterial blood gases reveal respiratory acidosis and hypoxemia. What is the priority nursing intervention to address the patient's current respiratory status?

C) Initiate high-flow oxygen therapy to improve oxygenation.

A) Increase the dosage of the patient's long-acting bronchodilator.

B) Administer intravenous corticosteroids to reduce inflammation.

C) Initiate high-flow oxygen therapy to improve oxygenation.

D) Prepare the patient for immediate intubation and mechanical ventilation.

A patient with a history of COPD is experiencing increased fatigue, worsening shortness of breath, and hypoxemia. Arterial blood gases show a pH of 7.32, PaCO2 of 52 mmHg, and PaO2 of 55 mmHg, indicating respiratory acidosis and hypoxemia. The patient also presents with a productive cough with yellow-green sputum and an elevated white blood cell count of 15,000/mm³. Considering these findings, which intervention should the nurse prioritize to prevent further deterioration?

B) Initiate high-flow oxygen therapy to improve oxygenation.

A) Administer a bronchodilator nebulizer treatment immediately.

B) Initiate high-flow oxygen therapy to improve oxygenation.

C) Prepare for intubation and mechanical ventilation.

A patient with a history of penicillin allergy and suspected pneumonia is receiving a respiratory fluoroquinolone and intravenous corticosteroids. Despite these interventions, the patient's respiratory distress persists with tachypnea and bilateral infiltrates on chest X-ray. Which nursing action is most appropriate to address the patient's current condition?

A) Increase the frequency of bronchodilator nebulization treatments.

B) Administer an antihistamine to manage the penicillin allergy.

C) Discontinue the corticosteroids due to potential side effects.

D) Start supplemental low-flow oxygen to reduce respiratory distress.

A patient with suspected pneumonia and a known penicillin allergy is being treated with a respiratory fluoroquinolone and intravenous corticosteroids. The nurse notes that the patient's respiratory rate remains elevated, and there is limited improvement in oxygen saturation and respiratory distress. Which of the following actions should the nurse prioritize to address the patient's current condition?

A) Increase the frequency of bronchodilator nebulizer treatments.

B) Request a consultation with an infectious disease specialist.

C) Administer a diuretic to reduce potential fluid overload.

D) Prepare the patient for intubation and mechanical ventilation.

A patient with COPD exacerbation is on high-flow oxygen support and has developed new symptoms, including increasing fatigue, lethargy, and elevated liver enzymes. Which intervention should the nurse prioritize to address the patient's current clinical status?

B) Consult with the healthcare provider regarding the potential adjustment or discontinuation of current medications.

A) Increase the flow rate of oxygen to improve oxygen saturation.

B) Consult with the healthcare provider regarding the potential adjustment or discontinuation of current medications.

C) Encourage the patient to perform deep breathing exercises hourly to improve ventilation.

D) Initiate a high-protein diet to support respiratory muscle strength.

A patient with a COPD exacerbation on the third day of hospitalization exhibits increasing fatigue, lethargy, and laboratory findings suggestive of drug-induced liver injury. Which nursing intervention is most appropriate to address the patient's respiratory status given the current clinical scenario?

B) Collaborate with the respiratory therapist to optimize non-invasive ventilation settings.

A) Increase the oxygen flow rate to improve oxygen saturation.

B) Collaborate with the respiratory therapist to optimize non-invasive ventilation settings.

C) Administer a bronchodilator to improve airway patency.

D) Encourage the patient to perform incentive spirometry to enhance lung expansion.

A patient with hepatic encephalopathy presents with intermittent confusion and elevated ammonia levels. What is the priority nursing intervention to reduce ammonia levels in this patient?

B) Administer lactulose as prescribed to promote bowel movements.

A) Restrict fluid intake to prevent dilutional hyponatremia.

B) Administer lactulose as prescribed to promote bowel movements.

C) Encourage a high-protein diet to enhance nutritional status.

D) Perform frequent neurological assessments to monitor changes.

A patient with suspected hepatic encephalopathy is showing intermittent confusion, asterixis, and elevated serum ammonia levels during hospitalization. What is the priority nursing intervention to address the patient's condition?

A) Administer lactulose as prescribed to reduce ammonia levels.

B) Encourage a high-protein diet to support nutritional needs.

C) Increase fluid intake to promote renal excretion of toxins.

D) Implement seizure precautions to prevent injury.

copd - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic inflammation in the airways and lung parenchyma leads to structural changes, including narrowing and obstruction, primarily due to the influx of inflammatory cells like neutrophils and macrophages, which release mediators causing tissue damage and fibrosis.

• Secondary mechanism: Imbalance between proteases and antiproteases results in the destruction of alveolar walls, leading to emphysema. This loss of elastic recoil impairs gas exchange and causes air trapping, reducing expiratory airflow.

• Key complication: Persistent airflow limitation and hyperinflation contribute to increased work of breathing, decreased exercise tolerance, and potential respiratory failure, necessitating vigilant monitoring and management in clinical settings.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: 20-year history of smoking (quit 5 years ago), hypertension, type 2 diabetes

• Current medications: Tiotropium, Metformin, Lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing shortness of breath and productive cough

• Key symptoms: Wheezing, fatigue, occasional chest tightness, frequent respiratory infections

• Vital signs: Blood pressure 145/90 mmHg, heart rate 98 bpm, respiratory rate 24 breaths per minute, oxygen saturation 88% on room air, temperature 37.5°C

Section 1

As the care team continues to monitor the patient, a new complication emerges. The patient begins to experience increased fatigue and worsening shortness of breath despite ongoing treatment. During a follow-up assessment, the nurse notices that the patient appears more cyanotic, particularly around the lips and fingertips. Upon auscultation, there are bilateral crackles in addition to wheezing, and the respiratory rate has further increased to 28 breaths per minute. Re-evaluation of oxygen saturation reveals a decrease to 84% on room air. The patient also reports a more frequent productive cough with yellow-green sputum, raising concerns about a potential acute exacerbation of COPD or superimposed infection.

Given these findings, the nurse draws arterial blood gases, which show a pH of 7.32, PaCO2 of 52 mmHg, and PaO2 of 55 mmHg, indicating respiratory acidosis and hypoxemia. These results suggest worsening ventilation-perfusion mismatch and potential impending respiratory failure. The nurse also notes an elevated white blood cell count of 15,000/mm³, which further supports the suspicion of an infectious process. To address the hypoxemia, supplemental oxygen is initiated, and the patient is placed on a high-flow oxygen device. The healthcare team discusses the need for further interventions, including possible adjustment of the bronchodilator regimen, initiation of corticosteroids, and empirical antibiotic therapy, considering the patient's penicillin allergy.

This development requires the healthcare team to reassess the patient's treatment plan and consider the potential need for hospitalization to prevent further deterioration. The clinical reasoning should focus on identifying the underlying cause of the exacerbation, optimizing respiratory support, and preventing further complications. The team must also consider the patient's comorbid conditions, such as diabetes and hypertension, in adjusting the treatment plan to ensure comprehensive care. This situation highlights the importance of close monitoring and prompt intervention in managing COPD exacerbations and preventing progression to respiratory failure.

Section 2

Following the initiation of supplemental high-flow oxygen, the patient's oxygen saturation improves modestly to 90%. However, despite this intervention, the patient continues to demonstrate significant respiratory distress with persistent tachypnea, now at 30 breaths per minute. The patient's blood pressure is noted to be 150/95 mmHg, with a heart rate of 110 beats per minute, suggesting increased cardiovascular strain. In light of the ongoing symptoms, the healthcare team decides to perform a chest X-ray to further investigate the cause of the exacerbation. The imaging reveals bilateral infiltrates, raising suspicion for pneumonia as a potential contributor to the acute deterioration.

In response to these findings, the healthcare team revises the treatment plan. Considering the patient's penicillin allergy, the team opts to start empirical antibiotic therapy with a respiratory fluoroquinolone, balancing the need for broad-spectrum coverage with the patient's allergy profile. Concurrently, intravenous corticosteroids are initiated to reduce airway inflammation and improve respiratory function. The bronchodilator regimen is adjusted to include more frequent nebulized treatments to optimize bronchodilation and improve airflow.

As the team implements these interventions, the patient's condition is closely monitored for signs of improvement or further decline. The elevated white blood cell count and productive cough remain under scrutiny, with sputum cultures ordered to identify potential pathogens and tailor antibiotic therapy. The interdisciplinary team, including respiratory therapists and pharmacists, collaborates to ensure the patient receives comprehensive care aimed at stabilizing the acute exacerbation and preventing progression to respiratory failure. The healthcare team remains vigilant, ready to escalate care should the patient's condition necessitate more intensive interventions, such as mechanical ventilation.

Section 3

Response to Interventions:

Following the implementation of the revised treatment plan, the healthcare team observes the patient closely for any signs of improvement or further complications. Over the next 48 hours, the patient's clinical status shows modest improvement. The respiratory rate decreases to 24 breaths per minute, and the oxygen saturation stabilizes at 92% on high-flow oxygen. The heart rate slightly decreases to 100 beats per minute, indicating a reduction in cardiovascular strain. The patient reports feeling slightly less breathless, although exertion still significantly exacerbates symptoms.

Laboratory results reveal a slight reduction in the elevated white blood cell count, suggesting a positive response to the antibiotic therapy. The sputum culture results identify Streptococcus pneumoniae as the causative pathogen, allowing the healthcare team to confirm the appropriateness of the chosen respiratory fluoroquinolone for targeted antibiotic therapy. The corticosteroids appear to be aiding in reducing airway inflammation, as evidenced by decreased wheezing and improved airflow during nebulized bronchodilator treatments.

Despite these encouraging signs, the patient begins to report new symptoms of gastrointestinal discomfort, including nausea and mild abdominal pain. The team suspects these symptoms may be side effects of the corticosteroid therapy or the antibiotic, prompting a review of the medication regimen. The pharmacist suggests adding a proton pump inhibitor to mitigate potential gastric irritation caused by corticosteroids, and the team discusses the need for further gastrointestinal evaluation if symptoms persist. This development requires careful monitoring to ensure that the new symptoms do not compromise the patient's recovery from the COPD exacerbation. As the patient’s condition continues to evolve, the healthcare team remains vigilant, ready to adjust the treatment plan to address both the primary respiratory condition and any emerging complications.

Section 4

New Complications:

As the patient progresses into the third day of hospitalization, the healthcare team notes a concerning change in the clinical picture. The patient begins to exhibit symptoms of increasing fatigue and lethargy, deviating from the modest improvements observed earlier. Vital signs reveal a slight rise in temperature to 37.9°C (100.2°F), and the heart rate has increased again to 108 beats per minute. Additionally, the respiratory rate has creeped up to 26 breaths per minute, while oxygen saturation remains at 91% despite continued high-flow oxygen support. These subtle changes prompt the team to reassess the current management strategy.

Laboratory tests are repeated to identify potential causes for the new developments. The results indicate a mild but notable elevation in liver enzymes, with AST and ALT levels rising to 78 U/L and 92 U/L, respectively. These findings suggest the development of drug-induced liver injury, potentially linked to the antibiotic or corticosteroid therapy. Moreover, the patient's renal function remains stable, ruling out acute kidney injury as a contributing factor. Concurrently, arterial blood gas analysis shows a slight increase in PaCO2 to 50 mmHg, indicative of worsening hypercapnia that may reflect respiratory muscle fatigue or suboptimal ventilation.

In response to these new complications, the healthcare team engages in clinical reasoning to address the emerging challenges. The decision is made to consult a hepatologist to evaluate the liver function abnormalities and consider alternative antibiotic options to minimize hepatotoxicity. Additionally, the respiratory therapy team is tasked with optimizing ventilatory support to manage the increased carbon dioxide levels. The patient's nutritional status is also reviewed to ensure adequate protein intake that supports muscle strength and recovery. This comprehensive approach aims to stabilize the patient's condition and prevent further deterioration while continuing to address the underlying COPD exacerbation. The team remains vigilant, ready to adapt the treatment plan as new diagnostic information becomes available.

Section 5

New Complications:

On the fifth day of hospitalization, the patient's condition presents additional complexities. Despite the adjusted interventions, the patient now experiences intermittent episodes of confusion and disorientation, signaling a potential decline in neurological status. This change prompts the healthcare team to conduct a thorough neurological assessment. The physical examination reveals a slight tremor in the patient's hands and mild asterixis, suggesting the possibility of hepatic encephalopathy due to the previously noted liver enzyme abnormalities. The patient's family reports that these symptoms are new and were not present prior to this hospital admission.

To investigate the neurocognitive changes, a CT scan of the brain is ordered, which returns normal, ruling out acute intracranial events such as hemorrhage or infarction. Additionally, a serum ammonia level is obtained, revealing a moderate elevation at 75 µmol/L, reinforcing the suspicion of hepatic encephalopathy. The hepatologist recommends initiating lactulose therapy to reduce ammonia levels and advises close monitoring of the patient's mental status.

In parallel, the respiratory therapy team has adjusted the patient's ventilatory support in response to the persistent hypercapnia. Despite these adjustments, the patient's oxygen saturation remains borderline, fluctuating between 89% and 91%, with a respiratory rate now steady at 28 breaths per minute. This highlights ongoing challenges in achieving optimal respiratory function. The team considers transitioning the patient to non-invasive positive pressure ventilation (NIPPV) to enhance alveolar ventilation and reduce CO2 retention. The patient's nutritional plan is also revised to emphasize low-protein intake, aiming to minimize ammonia production without compromising overall nutritional needs. As these interventions unfold, the healthcare team remains attentive to the patient's evolving condition, ready to adapt the treatment strategy based on the patient's response and any new developments.